Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.34 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.33 |
| ▸ | CDC25B | P30305 | 1/20 | 0.33 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16357610 | 0.90 | ALDH1A1 (0.50) | ALOX15MEN1KMT2ACYP3A4ALDH1A1 | |
| SCHEMBL7705960 | 0.88 | MEN1 (0.41) | ALOX15MEN1KMT2ACYP3A4ALDH1A1 | |
| SCHEMBL3895451 | 0.88 | MEN1 (0.41) | ALOX15MEN1KMT2ACYP3A4ALDH1A1 | |
| SCHEMBL18954258 | 0.85 | ALOX15 (0.34) | ALOX15MEN1KMT2ACYP3A4ALDH1A1 | |
| SCHEMBL11763336 | 0.83 | ALOX15 (0.41) | ALOX15MEN1KMT2ACYP3A4ALDH1A1 | |
| SCHEMBL3897447 | 0.83 | TSHR (0.46) | ALOX15MEN1KMT2ACYP3A4ALDH1A1 | |
| SCHEMBL13839555 | 0.83 | TSHR (0.46) | ALOX15MEN1KMT2ACYP3A4ALDH1A1 | |
| SCHEMBL20712528 | 0.82 | ALOX15 (0.33) | ALOX15MEN1KMT2ACYP3A4ALDH1A1 | |
| SCHEMBL29096779 | 0.82 | ALOX15 (0.40) | ALOX15MEN1KMT2ACYP3A4ALDH1A1 | |
| SCHEMBL13296191 | 0.81 | TSHR (0.44) | ALOX15MEN1KMT2ACYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1999 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3768502-B1 | INK COMPOSITION FOR COSMETIC CONTACT LENSES | JOHNSON & JOHNSON VISION CARE (US) | 2026-04-15 | — | — | EP | claimed |
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | claimed |
| US-12540110-B2 | Dihydroxylation of olefins using osmate (VI) salts | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2026-02-03 | — | — | US | claimed |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | GLYCOSCIENCE, S.L. (ES) | 2025-12-30 | — | — | US | claimed |
| CN-114945547-B | Dihydroxylation of olefins using osmium salts (VI) | 国际香料和香精公司 | 2025-06-17 | — | — | CN | claimed |
| CN-119959400-A | Method for simultaneously detecting 24 main fragrances in cosmetics | 湖北省普林标准技术服务有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-116535628-B | Food can welding seam easy-demolding powder coating and preparation method thereof | 江苏扬瑞新型材料股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | THE PROCTER & GAMBLE COMPANY (US) | 2025-02-25 | — | — | US | claimed |
| US-20250051370-A1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2025-02-13 | — | — | US | claimed |
| CN-115792012-B | Method for detecting aroma components of rose syrup and method for measuring aroma component content of rose syrup | 兰州海关技术中心 | 2024-12-20 | — | — | CN | claimed |
| US-5668102-A | SOLID OR LIQUID COMPOSITION CONTAINING CATIONIC QUATERNARY AMMONIUM FABRIC SOFTENING COMPOUND, NONIONIC OR ANIONIC ESTER OF NON-ALLYLIC ALCOHOL PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1997-09-16 | — | — | US | claimed |
| EP-0254784-B1 | PROCESS FOR SEPARATING MONOTERPENE COMPOUNDS | UOP INC. (US) | 1989-02-15 | — | — | EP | claimed |
| EP-0254784-A1 | Process for separating monoterpene compounds | UOP INC. (US) | 1988-02-03 | — | — | EP | claimed |
| US-4605783-A | IRON AND MIXED OXIDE CATALYST/ R TO ADSORB THE ALCOHOLS | UOP INC. (US) | 1986-08-12 | — | — | US | claimed |
| EP-0129684-A2 | Preparation of hydroxycitronellol | Union Camp Corporation (US) | 1985-01-02 | — | — | EP | claimed |
| US-4482765-A | HYDRATION OF CITRONELLOL, ION EXCHANGE RESIN | UNION CAMP CORPORATION (US) | 1984-11-13 | — | — | US | claimed |
| EP-0002498-B1 | PROCESS FOR PREPARING HYDROXYCITRONELLOL | BASF Aktiengesellschaft (DE) | 1981-09-09 | — | — | EP | claimed |
| US-4107219-A | OXIDIZING UNSATURATED AMINE, THERMAL REARRANGEMENT TO FORM UNSATURATED HYDROXYLAMINE, HYDROGENATION | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1978-08-15 | — | — | US | claimed |
| US-4056573-A | COUPLING, HYDROGENATION, SAPONIFICATION, ACID SCAVENGER, CUPROUS SALTN | SCM CORPORATION (US) | 1977-11-01 | — | — | US | claimed |
| US-3940446-A | Dehydrogenation of alcohols | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-02-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540110-B2 | Dihydroxylation of olefins using osmate (VI) salts | MSMO1, ADH5, ADH1C | ALOX15 340/4885MEN1 1066/4885KMT2A 4372/4885 |
| US-20250051370-A1 | SILICONE COMPOUNDS | SMCHD1, SRI, SMS | ALOX15 2271/4885MEN1 49/4885KMT2A 1800/4885 |
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | SMS, SRM, AAAS | ALOX15 2826/4885MEN1 31/4885KMT2A 396/4885 |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | EBP, MGAT1, MGAT3 | ALOX15 3075/4885MEN1 3970/4885KMT2A 1805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.